MTOR and non-small cell lung carcinoma: In summary, we demonstrated that EGFR mutant NSCLC cell lines had different activation of mTOR-associated signaling pathways in the basal state and mTORC2-associated Akt ser473-FOXO1 signaling pathway was highly activated in resistant cells.